Hip Surgery Device Market to Reach USD 12.5 Billion by 2033 at a 5.8% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - Rising rates of osteoarthritis and rheumatoid arthritis, a growing elderly population, and wider use of robotic-assisted and computer-assisted surgery are reshaping demand for hip surgery devices. According to Strategic Revenue Insights, the global hip surgery device market is projected to reach USD 12.5 billion by 2033, registering a CAGR of 5.8% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 12.5 billion by 2033, at a CAGR of 5.8% from 2025 to 2033.
• Total hip replacement implants are the most commonly used implant type and account for a significant share of the market.
• Robotic-assisted surgery systems, minimally invasive techniques, and biocompatible biomaterials such as bone cement and biological grafts are key technology trends.
• North America holds the largest market share, while Asia Pacific is expected to witness the fastest growth.
• Named market participants include Zimmer Biomet Holdings, Inc., Stryker Corporation, and DePuy Synthes (Johnson & Johnson).

Report URL: https://www.strategicrevenueinsights.com/industry/hip-surgery-device-market

Aging Populations and Robotic-Assisted Surgery Drive Demand

The increasing prevalence of hip-related disorders such as osteoarthritis and rheumatoid arthritis is the primary growth driver. These conditions are more common in older adults, and the global geriatric population continues to expand. Lifestyle changes and rising obesity rates add further stress to hip joints, increasing the need for surgical intervention.

Technology is reshaping how hip surgeries are performed. Robotic-assisted and computer-assisted navigation systems improve surgical precision, patient outcomes, and recovery times, while patients increasingly prefer minimally invasive procedures that offer reduced pain and shorter hospital stays. New biomaterials with improved biocompatibility and durability are also supporting market growth, and regulatory approvals and favorable reimbursement policies are aiding expansion.

Market Segmentation

By Implants: The market includes Total Hip Replacement Implants, Partial Hip Replacement Implants, and Revision Hip Replacement Implants. Total hip replacement implants are the most commonly used devices and account for a significant share of the market.

By Surgical Instruments: Instruments include Reamers, Rasps, and Surgical Saws, with demand supported by the growing number of hip replacement surgeries and the shift toward minimally invasive techniques.

By Navigation Systems: The segment covers Computer-Assisted Surgery Systems and Robotic-Assisted Surgery Systems, which enhance surgical precision and accuracy. The source does not identify a largest or fastest-growing navigation system.

By Fixation Devices: Fixation devices include Plates and Screws and Intramedullary Nails, used to stabilize bone during hip fracture and long bone procedures.

By Biomaterials: Biomaterials include Bone Cement and Biological Grafts, which are gaining traction because of their biocompatibility and effectiveness.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest share of the market, while Asia Pacific is anticipated to witness the fastest growth during the forecast period. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Zimmer Biomet Holdings, Inc., Stryker Corporation, and DePuy Synthes (Johnson & Johnson) among the leading participants. Zimmer Biomet is known for a comprehensive portfolio of orthopedic implants and surgical instruments. Stryker is recognized for advanced surgical technologies, including robotic-assisted and computer-assisted navigation systems. DePuy Synthes offers a comprehensive range of orthopedic implants and instruments. Other named companies include Smith & Nephew plc, Medtronic plc, Conformis, Inc., Exactech, Inc., MicroPort Scientific Corporation, Wright Medical Group N.V., DJO Global, Inc., Corin Group, Arthrex, Inc., Integra LifeSciences Corporation, and NuVasive, Inc.

Market Restraints

The high cost of advanced surgical devices and technologies can limit adoption, particularly in developing regions with limited healthcare budgets. Stringent regulatory requirements for medical devices also increase the time and cost of bringing new products to market.

Related Reports

https://www.strategicrevenueinsights.com/industry/geriatrics-carts-market

https://www.strategicrevenueinsights.com/industry/vacuum-cupping-market

https://www.strategicrevenueinsights.com/industry/medical-gas-alarm-system-market

https://www.strategicrevenueinsights.com/industry/medical-gas-outlets-market

https://www.strategicrevenueinsights.com/industry/medical-vacuum-station-market

https://www.strategicrevenueinsights.com/industry/enteral-nutrition-pumps-market

https://www.strategicrevenueinsights.com/industry/polysomnograph-market

https://www.strategicrevenueinsights.com/industry/intracranial-monitoring-equipment-market

https://www.strategicrevenueinsights.com/industry/hearing-screening-apparatus-market

https://www.strategicrevenueinsights.com/industry/visual-screening-apparatus-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 12.5 billion by 2033.

What is the expected CAGR of the hip surgery device market?

The market is projected to expand at a CAGR of 5.8% from 2025 to 2033.

Which segment is largest in the hip surgery device market?

Total hip replacement implants are the most commonly used devices in hip surgeries and account for a significant share of the market.

Which region leads the hip surgery device market?

North America holds the largest share of the market, while Asia Pacific is anticipated to witness the fastest growth during the forecast period.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases